FHIR IG analytics| Package | de.medizininformatikinitiative.kerndatensatz.onkologie |
| Resource Type | ValueSet |
| Id | ValueSet-mii-vs-onko-marker-gene-hgnc.json |
| FHIR Version | R4 |
| Source | https://medizininformatik-initiative.github.io/kerndatensatzmodul-onkologie/2027.0.0-ballot.1/ValueSet-mii-vs-onko-marker-gene-hgnc.html |
| URL | https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-marker-gene-hgnc |
| Version | 2027.0.0-ballot.1 |
| Status | active |
| Date | 2026-09-15T06:26:59+00:00 |
| Name | MII_VS_Onko_Marker_Gene_HGNC |
| Title | MII VS Onkologie Marker-Gene HGNC |
| Realm | de |
| Description | Gensymbole der onkologisch gebraeuchlichen Marker-Gene aus der Genetik-Markerliste der §65c-Plattform, als HGNC-Gen-IDs. Auswahlunterstuetzung fuer Observation.component:gene-studied im Profil MII_PR_Onko_Genetische_Variante (extensible gebunden — weitere Gene sind zulaessig). Nicht-Gene der Quellliste (IHC-Marker, zytogenetische Aberrationen) sind bewusst ausgeschlossen; siehe die Kommentare in der FSH-Quelle und die IG-Seite zu den Variantentypen. |
| StructureDefinition | ||
| de.medizininformatikinitiative.kerndatensatz.onkologie#2027.0.0-ballot.1 | mii-pr-onko-genetische-variante | MII PR Onkologie Genetische Variante |
No resources found
Note: links and images are rebased to the (stated) source
English
Generated Narrative: ValueSet mii-vs-onko-marker-gene-hgnc
Profiles: Shareable ValueSet, CRMI Shareable ValueSet, CRMI Publishable ValueSet, CRMI Computable ValueSet
FHIR
FHIRsmithhttp://www.genenames.org/geneId version ⏿20250704| Code | Display | Definition |
| HGNC:76 | ABL1 | ABL proto-oncogene 1, non-receptor tyrosine kinase |
| HGNC:427 | ALK | ALK receptor tyrosine kinase |
| HGNC:1097 | BRAF | B-Raf proto-oncogene, serine/threonine kinase |
| HGNC:1100 | BRCA1 | BRCA1 DNA repair associated |
| HGNC:1101 | BRCA2 | BRCA2 DNA repair associated |
| HGNC:1133 | BTK | Bruton tyrosine kinase |
| HGNC:2561 | CXCR4 | C-X-C motif chemokine receptor 4 |
| HGNC:3236 | EGFR | epidermal growth factor receptor |
| HGNC:3430 | ERBB2 | erb-b2 receptor tyrosine kinase 2 |
| HGNC:3689 | FGFR2 | fibroblast growth factor receptor 2 |
| HGNC:3765 | FLT3 | fms related receptor tyrosine kinase 3 |
| HGNC:5382 | IDH1 | isocitrate dehydrogenase (NADP(+)) 1 |
| HGNC:5383 | IDH2 | isocitrate dehydrogenase (NADP(+)) 2 |
| HGNC:6342 | KIT | KIT proto-oncogene, receptor tyrosine kinase |
| HGNC:13726 | KMT2C | lysine methyltransferase 2C |
| HGNC:6407 | KRAS | KRAS proto-oncogene, GTPase |
| HGNC:6470 | L1CAM | L1 cell adhesion molecule |
| HGNC:6840 | MAP2K1 | mitogen-activated protein kinase kinase 1 |
| HGNC:7029 | MET | MET proto-oncogene, receptor tyrosine kinase |
| HGNC:7059 | MGMT | O-6-methylguanine-DNA methyltransferase |
| HGNC:7562 | MYD88 | MYD88 innate immune signal transduction adaptor |
| HGNC:7765 | NF1 | neurofibromin 1 |
| HGNC:7910 | NPM1 | nucleophosmin 1 |
| HGNC:7989 | NRAS | NRAS proto-oncogene, GTPase |
| HGNC:7997 | NRG1 | neuregulin 1 |
| HGNC:8031 | NTRK1 | neurotrophic receptor tyrosine kinase 1 |
| HGNC:8032 | NTRK2 | neurotrophic receptor tyrosine kinase 2 |
| HGNC:8033 | NTRK3 | neurotrophic receptor tyrosine kinase 3 |
| HGNC:8803 | PDGFRA | platelet derived growth factor receptor alpha |
| HGNC:8975 | PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| HGNC:9177 | POLE | DNA polymerase epsilon, catalytic subunit |
| HGNC:9864 | RARA | retinoic acid receptor alpha |
| HGNC:9967 | RET | ret proto-oncogene |
| HGNC:10261 | ROS1 | ROS proto-oncogene 1, receptor tyrosine kinase |
| HGNC:10680 | SDHA | succinate dehydrogenase complex flavoprotein subunit A |
| HGNC:10681 | SDHB | succinate dehydrogenase complex iron sulfur subunit B |
| HGNC:10682 | SDHC | succinate dehydrogenase complex subunit C |
| HGNC:10683 | SDHD | succinate dehydrogenase complex subunit D |
| HGNC:25941 | TET2 | tet methylcytosine dioxygenase 2 |
| HGNC:11998 | TP53 | tumor protein p53 |
German
Generated Narrative: ValueSet mii-vs-onko-marker-gene-hgnc
Profiles: Shareable ValueSet, CRMI Shareable ValueSet, CRMI Publishable ValueSet, CRMI Computable ValueSet
http://www.genenames.org/geneId version ⏿20250704| Code | Display | Definition |
| HGNC:76 | ABL1 | ABL proto-oncogene 1, non-receptor tyrosine kinase |
| HGNC:427 | ALK | ALK receptor tyrosine kinase |
| HGNC:1097 | BRAF | B-Raf proto-oncogene, serine/threonine kinase |
| HGNC:1100 | BRCA1 | BRCA1 DNA repair associated |
| HGNC:1101 | BRCA2 | BRCA2 DNA repair associated |
| HGNC:1133 | BTK | Bruton tyrosine kinase |
| HGNC:2561 | CXCR4 | C-X-C motif chemokine receptor 4 |
| HGNC:3236 | EGFR | epidermal growth factor receptor |
| HGNC:3430 | ERBB2 | erb-b2 receptor tyrosine kinase 2 |
| HGNC:3689 | FGFR2 | fibroblast growth factor receptor 2 |
| HGNC:3765 | FLT3 | fms related receptor tyrosine kinase 3 |
| HGNC:5382 | IDH1 | isocitrate dehydrogenase (NADP(+)) 1 |
| HGNC:5383 | IDH2 | isocitrate dehydrogenase (NADP(+)) 2 |
| HGNC:6342 | KIT | KIT proto-oncogene, receptor tyrosine kinase |
| HGNC:13726 | KMT2C | lysine methyltransferase 2C |
| HGNC:6407 | KRAS | KRAS proto-oncogene, GTPase |
| HGNC:6470 | L1CAM | L1 cell adhesion molecule |
| HGNC:6840 | MAP2K1 | mitogen-activated protein kinase kinase 1 |
| HGNC:7029 | MET | MET proto-oncogene, receptor tyrosine kinase |
| HGNC:7059 | MGMT | O-6-methylguanine-DNA methyltransferase |
| HGNC:7562 | MYD88 | MYD88 innate immune signal transduction adaptor |
| HGNC:7765 | NF1 | neurofibromin 1 |
| HGNC:7910 | NPM1 | nucleophosmin 1 |
| HGNC:7989 | NRAS | NRAS proto-oncogene, GTPase |
| HGNC:7997 | NRG1 | neuregulin 1 |
| HGNC:8031 | NTRK1 | neurotrophic receptor tyrosine kinase 1 |
| HGNC:8032 | NTRK2 | neurotrophic receptor tyrosine kinase 2 |
| HGNC:8033 | NTRK3 | neurotrophic receptor tyrosine kinase 3 |
| HGNC:8803 | PDGFRA | platelet derived growth factor receptor alpha |
| HGNC:8975 | PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| HGNC:9177 | POLE | DNA polymerase epsilon, catalytic subunit |
| HGNC:9864 | RARA | retinoic acid receptor alpha |
| HGNC:9967 | RET | ret proto-oncogene |
| HGNC:10261 | ROS1 | ROS proto-oncogene 1, receptor tyrosine kinase |
| HGNC:10680 | SDHA | succinate dehydrogenase complex flavoprotein subunit A |
| HGNC:10681 | SDHB | succinate dehydrogenase complex iron sulfur subunit B |
| HGNC:10682 | SDHC | succinate dehydrogenase complex subunit C |
| HGNC:10683 | SDHD | succinate dehydrogenase complex subunit D |
| HGNC:25941 | TET2 | tet methylcytosine dioxygenase 2 |
| HGNC:11998 | TP53 | tumor protein p53 |
{
"resourceType": "ValueSet",
"id": "mii-vs-onko-marker-gene-hgnc",
"meta": {
"extension": [
{
"url": "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-license",
"valueCode": "CC-BY-4.0"
},
{
"extension": [
{
"url": "packageId",
"valueId": "de.medizininformatikinitiative.kerndatensatz.onkologie"
},
{
"url": "version",
"valueString": "2027.0.0-ballot.1"
},
{
"url": "uri",
"valueUri": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/package-source"
}
],
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablevalueset",
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablevalueset",
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-computablevalueset"
]
},
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode": "shareable"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode": "publishable"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode": "computable"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-versionPolicy",
"valueCodeableConcept": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/artifact-version-policy-codes",
"code": "package",
"display": "Package"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-approvalDate",
"valueDate": "2026-09-15"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-topic",
"valueCodeableConcept": {
"coding": [
{
"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"code": "C3262"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail": {
"telecom": [
{
"system": "email",
"value": "thomas.debertshaeuser@charite.de"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-editor",
"valueContactDetail": {
"name": "Taskforce Core Data Set"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-reviewer",
"valueContactDetail": {
"name": "Interoperability Working Group",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/interoperability-working-group"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-reviewer",
"valueContactDetail": {
"name": "National Steering Committee",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/national-steering-committee"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-endorser",
"valueContactDetail": {
"name": "Interoperability Working Group",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/interoperability-working-group"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-endorser",
"valueContactDetail": {
"name": "National Steering Committee",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/en/collaboration/national-steering-committee"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-versionAlgorithm",
"valueCoding": {
"system": "http://hl7.org/fhir/version-algorithm",
"code": "semver",
"display": "SemVer"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-effectivePeriod",
"valuePeriod": {
"start": "2027"
}
}
],
"url": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-marker-gene-hgnc",
"version": "2027.0.0-ballot.1",
"name": "MII_VS_Onko_Marker_Gene_HGNC",
"title": "MII VS Onkologie Marker-Gene HGNC",
"status": "active",
"experimental": false,
"date": "2026-09-15T06:26:59+00:00",
"publisher": "Medizininformatik Initiative",
"contact": [
{
"name": "Medizininformatik Initiative",
"telecom": [
{
"system": "url",
"value": "https://www.medizininformatik-initiative.de/"
}
]
}
],
"description": "Gensymbole der onkologisch gebraeuchlichen Marker-Gene aus der Genetik-Markerliste der §65c-Plattform, als HGNC-Gen-IDs. Auswahlunterstuetzung fuer Observation.component:gene-studied im Profil MII_PR_Onko_Genetische_Variante (extensible gebunden — weitere Gene sind zulaessig). Nicht-Gene der Quellliste (IHC-Marker, zytogenetische Aberrationen) sind bewusst ausgeschlossen; siehe die Kommentare in der FSH-Quelle und die IG-Seite zu den Variantentypen.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "DE",
"display": "Germany"
}
]
}
],
"compose": {
"include": [
{
"system": "http://www.genenames.org/geneId",
"concept": [
{
"code": "HGNC:76",
"display": "ABL1"
},
{
"code": "HGNC:427",
"display": "ALK"
},
{
"code": "HGNC:1097",
"display": "BRAF"
},
{
"code": "HGNC:1100",
"display": "BRCA1"
},
{
"code": "HGNC:1101",
"display": "BRCA2"
},
{
"code": "HGNC:1133",
"display": "BTK"
},
{
"code": "HGNC:2561",
"display": "CXCR4"
},
{
"code": "HGNC:3236",
"display": "EGFR"
},
{
"code": "HGNC:3430",
"display": "ERBB2"
},
{
"code": "HGNC:3689",
"display": "FGFR2"
},
{
"code": "HGNC:3765",
"display": "FLT3"
},
{
"code": "HGNC:5382",
"display": "IDH1"
},
{
"code": "HGNC:5383",
"display": "IDH2"
},
{
"code": "HGNC:6342",
"display": "KIT"
},
{
"code": "HGNC:13726",
"display": "KMT2C"
},
{
"code": "HGNC:6407",
"display": "KRAS"
},
{
"code": "HGNC:6470",
"display": "L1CAM"
},
{
"code": "HGNC:6840",
"display": "MAP2K1"
},
{
"code": "HGNC:7029",
"display": "MET"
},
{
"code": "HGNC:7059",
"display": "MGMT"
},
{
"code": "HGNC:7562",
"display": "MYD88"
},
{
"code": "HGNC:7765",
"display": "NF1"
},
{
"code": "HGNC:7910",
"display": "NPM1"
},
{
"code": "HGNC:7989",
"display": "NRAS"
},
{
"code": "HGNC:7997",
"display": "NRG1"
},
{
"code": "HGNC:8031",
"display": "NTRK1"
},
{
"code": "HGNC:8032",
"display": "NTRK2"
},
{
"code": "HGNC:8033",
"display": "NTRK3"
},
{
"code": "HGNC:8803",
"display": "PDGFRA"
},
{
"code": "HGNC:8975",
"display": "PIK3CA"
},
{
"code": "HGNC:9177",
"display": "POLE"
},
{
"code": "HGNC:9864",
"display": "RARA"
},
{
"code": "HGNC:9967",
"display": "RET"
},
{
"code": "HGNC:10261",
"display": "ROS1"
},
{
"code": "HGNC:10680",
"display": "SDHA"
},
{
"code": "HGNC:10681",
"display": "SDHB"
},
{
"code": "HGNC:10682",
"display": "SDHC"
},
{
"code": "HGNC:10683",
"display": "SDHD"
},
{
"code": "HGNC:25941",
"display": "TET2"
},
{
"code": "HGNC:11998",
"display": "TP53"
}
]
}
]
}
}